CBFB/MYH11 inv(16), Quantitative, Real-Time PCR

The CBFB/MYH11 inv(16), Quantitative, Real-Time PCR test contains 1 test with 1 biomarker.

This Real-Time Quantitative (Reverse Transcription Polymerase Chain Reaction) for the amplification of CBFB/MYH11 fusion transcript can be used to detect the chromosome aberration of inv (16) or t (16;16). It can be used to detect Minimal Residual Disease (MRD) and assess the risk for disease relapse in inv (16) or t (16;16) Acute Myeloid Leukemia (AML).

The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.

Also known as: CBFBMYH11 inv16 Quantitative RealTime PCR

Cbfb/Myh11 Inv (16)